PFIZER’S TUKYSA REGIMEN RECEIVES FDA APPROVAL AS FRONT-LINE MAINTENANCE TREATMENT FOR HER2+ METASTATIC BREAST CANCER

Reuters · 2d ago

Please log in to view news